Batavia Biosciences
Zernikedreef 16
2333 CL
Leiden
Netherlands
Tel: +31 88 9950600
Website: https://www.bataviabiosciences.com/
Email: Info@bataviabiosciences.com
About Batavia Biosciences
U.S. Location:
Batavia Biosciences Inc.
Address:
300 TradeCenter Drive Suite 6650
Woburn, MA 01801
United States
Email:
Info@bataviabiosciences.com
Phone:
+1 781 305 3921
15 articles about Batavia Biosciences
-
Batavia Biosciences Optimizes Global Quality Assurance with Veeva Vault Quality Suite
9/15/2022
Veeva Systems (NYSE: VEEV) today announced Batavia Biosciences selected Veeva Vault Quality Suite to optimize its global quality assurance (QA), unifying content, processes, and training management on a single platform.
-
Batavia Biosciences successfully manufactures IAVI’s Lassa fever vaccine candidate on innovative HIP-Vax platform to support Phase I clinical trials
7/14/2021
Batavia Biosciences announces today that they have successfully produced vaccine material for a Phase I clinical trial of IAVI’s Lassa fever vaccine candidate, rVSV∆G-LASV-GPC.
-
Batavia Biosciences to develop innovative clinical process for RocketVax’s second generation COVID-19 vaccine
7/6/2021
Today, Batavia Biosciences announces their collaboration with RocketVax, a subsidiary of Swiss Rockets AG developing vaccines based on breakthrough genetic engineering.
-
BioSpace Global Roundup, June 18
6/18/2020
Biopharma and life sciences companies from across the globe provide updates on their pipelines and business operations. -
The Wistar Institute and Batavia Biosciences Launch Collaboration to Manufacture and Distribute Wistar’s Rubella Vaccine Globally
4/29/2020
The Bill & Melinda Gates Foundation supports international collaboration to expand global access to life-saving vaccines
-
IAVI and Batavia Biosciences Announce Collaboration on VSV-vector Based Epidemic Preparedness Vaccines
3/5/2020
Mutual expertise drives innovations to address supply issues for vaccines for outbreak pathogens
-
BioSpace Global Roundup, Sept. 5
9/5/2019
Companies from across Europe and Asia share updates on their business and pipelines. -
Batavia Biosciences to deploy Horizon Discovery’s CHO cell technology to develop anti-Zika biotherapeutic with Vanderbilt University Medical Center and IDBiologics
9/3/2019
Batavia Biosciences announced that the company has signed a license agreement to utilize Horizon Discovery’s GS knockout CHO K1 cell line expression system for the development of high yield antibody-expressing cell lines.
-
Batavia Biosciences Partners with IAVI to Advance Development of Vaccine Against Lassa Fever
12/11/2018
Batavia Biosciencesannounces today that the International AIDS Vaccine Initiative (IAVI) and Batavia Biosciences will work together under a grant to advance the development of a Lassa fever vaccine.
-
Batavia Biosciences Teams Up With International Consortium to Support Polio Eradicationvv
1/16/2018
The project, funded by the Bill & Melinda Gates Foundation, has the potential to bolster efforts to sustain a polio-free world after the disease has been eradicated.
-
Batavia Biosciences Expands Its Viral Vector And GMP Facilities To Accommodate Increasing Market Demand
10/16/2017
Today, Batavia Biosciences announces the expansion of its viral vector process development facilities in the USA and its GMP clean room facilities in the Netherlands to accommodate the increasing market demand.
-
Batavia Bioservices and UvA Holding Announce STEP Technology Exclusive License
4/29/2013
-
Batavia Bioservices Opens Laboratory Facility in Greater Boston Area
6/18/2012
-
Batavia Bioservices Opens Laboratory Facility in Greater Boston Area
6/13/2012
-
Batavia Bioservices and Xendo Announce Business Collaboration
8/26/2011